Physician profile

Dane E Clarke

Emergency Medicine · Perth Amboy, NJ

NPI 1710988050

$1,313.29

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$394.03

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Inari Medical, INC. $679.71 2021-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Janssen Pharmaceuticals, INC $192.10 2020-2024 Xarelto
Portola Pharmaceuticals, LLC $136.71 2019
Alexion Pharmaceuticals, INC. $117.78 2021
Abbvie INC. $112.90 2021-2024 Dalvance, Teflaro, Avycaz
Boston Scientific Corporation $32.65 2023 Watchman Access System
Csl Behring $26.99 2022
E.R. Squibb & Sons, L.L.C. $14.45 2024 Eliquis

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Dane E Clarke

$1,313.29

in general payments reported 2019-2025

Years
2019-2024
Top company
Inari Medical, INC.

https://glasscript.com/doctor/526341/dane-e-clarke

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.